Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Royal Marsden NHS Foundation Trust: Clinical Trials & FDA Approval Profile

Royal Marsden NHS Foundation Trust (Global / Institutional) sponsors 17 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 5 active protocols (2 recruiting now), 5 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)17.6%
Median Closed Enrollment vs National (145 pts)32 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Royal Marsden NHS Foundation Trust
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)17
Active Pipeline (Recruiting Now)5 (2)
Completed vs Stopped Early5 / 3 (17.6%)
Median Closed Actual Enrollment32 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Royal Marsden NHS Foundation Trust
Hospital Research SiteLocationShared Protocols
The Royal Marsden NHS Foundation TrustLondon5
University College London HospitalLondon3
The Christie NHS Foundation TrustManchester3

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Royal Marsden NHS Foundation Trust
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT04985266A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant VersusPhase IIRECRUITING
NCT04920708Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA SuppressionPhase IIACTIVE NOT RECRUITING

Explore interactive annual charts and M&A subsidiary rollups in the Royal Marsden NHS Foundation Trust Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI